GMAB

Genmab

• PUBT·3d ago

  Genmab to present epcoritamab data at ASCO, EHA meetings

• PUBT·3d ago

  Genmab presents Phase 3 EPCORE DLBCL-1 results for epcoritamab at EHA 2026

• TipRanks·3d ago

  Charlie Haywood Reiterates Buy on Genmab, Keeps DKK 2,500 Price Target on Strength of Late-Stage Pipeline and Favorable Risk-Reward

• TipRanks·4d ago

  Genmab (OTC) Maps Catalyst-Rich Path After Strong Q1

• TipRanks·5d ago

  Analyst Maintains Buy on Genmab as Expanded Petosemtamab Phase III Program Strengthens Late-Stage HNSCC Outlook

• TipRanks·05/15 09:25

  Genmab: Buy Rating Reiterated on Strong Clinical Catalysts, Unchanged DKK 2,500 Price Target

• TipRanks·05/15 00:25

  Genmab Earnings Call: Strong Growth, Big Pipeline Bets

• TipRanks·05/13 14:48

  Genmab Updates Articles of Association, Expands Capital and Incentive Authorizations

• TipRanks·05/12 18:17

  Genmab Announces Minor Capital Increase Following Employee Warrant Exercise

• PUBT·05/12 17:50

  Genmab issued share capital totals 62,353,067 shares, voting rights match after increase

• PUBT·05/12 17:47

  Genmab issues 2,346 shares after employee warrant exercise, raising about DKK 3 million

• TipRanks·05/12 06:22

  Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Caris Life Sciences, Inc. (CAI)

• TipRanks·05/11 17:36

  Genmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche Bank

• TipRanks·05/09 21:35

  Genmab A/S (0MGB) Receives a Buy from Goldman Sachs

• TipRanks·05/09 01:36

  Genmab A/S (0MGB) Gets a Hold from Kepler Capital